早期肝细胞癌与高级别异型增生结节的超声造影特征:与组织病理学表现的相关性
本回顾性研究纳入81例患者共85个经病理证实的肝脏病灶(69个早期肝细胞癌和16个高级别异型增生结节),术前或活检前用SonoVue行超声造影,评估增强特征并与组织病理学对照。早期肝细胞癌与高级别异型增生结节的超声造影增强模式存在显著差异,早期肝细胞癌中肝窦内皮细胞CD34弥漫表达与动脉期高增强相关。
要点
- 早期肝细胞癌的主要增强模式为动脉期高增强且门静脉期/延迟期无廓清(20/69,29.0%)。
- 所有高级别异型增生结节均未观察到廓清,其主要模式为动脉期等增强且门静脉期/延迟期无廓清(7/16,43.8%)。
- 早期肝细胞癌肝窦内皮细胞CD34弥漫表达比例高于高级别异型增生结节(56.5% vs 12.5%,P=.001),且与动脉期增强模式相关(P=.039)。
核心结论
- 早期肝细胞癌与高级别异型增生结节在超声造影上的增强模式存在显著差异。
- 早期肝细胞癌中肝窦内皮细胞CD34弥漫表达与超声造影动脉期高增强相关。
研究设计与样本
- 回顾性研究,纳入81例患者共85个经病理证实的肝脏病灶(69个早期肝细胞癌和16个高级别异型增生结节)。
- 所有病灶在手术或活检前接受SonoVue(Bracco SpA,米兰,意大利)超声造影检查。
- 评估早期肝细胞癌与高级别异型增生结节的增强特征并与组织病理学表现进行比较。
关键影像表现/征象
- 38个(55.1%)早期肝细胞癌表现为动脉期高增强。
- 早期肝细胞癌的主要增强模式为动脉期高增强且门静脉期/延迟期无廓清(20/69,29.0%)。
- 8个(11.6%)早期肝细胞癌表现为动脉期高增强。
- 30个(43.5%)早期肝细胞癌观察到廓清,其中16个(23.2%)表现为极晚期廓清(>120秒)。
- 所有高级别异型增生结节均未观察到廓清,16个中7个(43.8%)的主要增强模式为动脉期等增强且门静脉期/延迟期无廓清。
诊断标准与关键数值
- 极晚期廓清定义为廓清时间>120秒,见于16个(23.2%)早期肝细胞癌。
- 早期肝细胞癌肝窦内皮细胞CD34弥漫表达比例为56.5%,高级别异型增生结节为12.5%(P=.001)。
- 早期肝细胞癌超声造影动脉期增强模式与CD34表达程度相关(P=.039)。
临床应用与阅片要点
- 阅片时需注意早期肝细胞癌可表现为动脉期高增强且门静脉期/延迟期无廓清(29.0%),并非所有早期肝细胞癌均出现廓清。
- 高级别异型增生结节在本组中均未出现廓清,动脉期等增强且门静脉期/延迟期无廓清为其主要模式(43.8%)。
- 早期肝细胞癌可出现极晚期廓清(>120秒,占23.2%),观察延迟期表现有助于鉴别。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To explore the enhancement features of early hepatocellular carcinoma (HCC, including well-differentiated HCC and high-grade dysplastic nodules with a focus of HCC) and high-grade dysplastic nodules (HGDNs) on contrast-enhanced ultrasound (CEUS), correlated with the histopathologic findings.
METHODS: This retrospective study enrolled 81 patients with 85 pathologically confirmed hepatic lesions (69 early HCCs and 16 HGDNs). All of the hepatic lesions were examined by CEUS with SonoVue (Bracco SpA, Milan, Italy) before surgery or biopsy. The enhancement features of early HCCs and HGDNs were evaluated and compared with histopathologic findings.
RESULTS: Thirty-eight (55.1%) early HCCs showed arterial-phase hyperenhancement (APHE). The major enhancement pattern of early HCCs was APHE without portal venous/late-phase wash-out (20 of 69 [29.0%]). Eight (11.6%) early HCCs manifested APHE. Wash-out was observed in 30 (43.5%) early HCCs. Sixteen (23.2%) early HCCs showed very-late wash-out (>120 seconds). Wash-out was not observed in all HGDNs. Of the 16 HGDNs, arterial-phase isoenhancement without portal venous/late-phase wash-out was the major enhancement pattern (n = 7 [43.8%]). The degree of CD34 expression of sinusoidal endothelial cells was more diffuse in early HCCs than in HGDNs (56.5% versus 12.5%; P = .001). Arterial-phase enhancement patterns of early HCCs on CEUS were correlated with the degree of CD34 expression (P = .039).
CONCLUSIONS: Enhancement patterns were significantly different between early HCCs and HGDNs on CEUS. Diffuse CD34 expression of sinusoidal endothelial cells in early HCC was correlated with APHE on CEUS.
引用
- Fan PL, Xia HS, Ding H, et al. Characterization of Early Hepatocellular Carcinoma and High-Grade Dysplastic Nodules on Contrast-Enhanced Ultrasound: Correlation With Histopathologic Findings. J Ultrasound Med. 2020. PMID: 32378794. doi:10.1002/jum.15288
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。